Sugi Predict

Sugi Predict / Compounds / SCHEMBL17595095

SCHEMBL17595095

SCHEMBL17595095

Cc1nc2cc(Br)cc(Cl)c2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ CSNK2A1 P68400 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ TYMS P04818 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ CYP1A2 P05177 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ NQO2 P16083 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ PTGES O14684 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23473991 0.85 ALDH1A1 (0.43) ALDH1A1CSNK2A1HTTPARP1TYMS
SCHEMBL16801763 0.81 NQO2 (0.42) ALDH1A1CSNK2A1PARP1TYMSSMN1; SMN2
SCHEMBL9505765 0.81 HTT (0.52) ALDH1A1CSNK2A1HTTPARP1TYMS
SCHEMBL17487366 0.81 NMT1 (0.31) PTGES
SCHEMBL17702657 0.81 CSNK2A1 (0.39) ALDH1A1CSNK2A1HTTPARP1TYMS
SCHEMBL1286353 0.78 ALDH1A1 (0.41) ALDH1A1CSNK2A1HTTPARP1TYMS
SCHEMBL13351381 0.78 ALDH1A1 (0.41) ALDH1A1CSNK2A1HTTPARP1TYMS
SCHEMBL1285923 0.75 KDM4E (0.43) ALDH1A1CSNK2A1HTTPARP1TYMS
SCHEMBL28592630 0.75 ALDH1A1 (0.39) ALDH1A1CSNK2A1HTTPARP1TYMS
SCHEMBL23478355 0.75 ALDH1A1 (0.39) ALDH1A1CSNK2A1HTTPARP1TYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074828-B Compounds and compositions as RAF kinase inhibitors 诺华股份有限公司 2020-05-19 — — CN disclosed
EP-3191478-B1 COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS NOVARTIS AG (CH) 2019-05-08 — — EP disclosed
US-10167279-B2 Compounds and compositions as RAF kinase inhibitors NOVARTIS AG (CH) 2019-01-01 — — US disclosed
US-20180170917-A1 COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2018-06-21 — — US disclosed
US-20180170917-A1 COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2018-06-21 — — US disclosed
EP-3191478-A1 COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS Novartis AG (CH) 2017-07-19 — — EP disclosed
WO-2016038582-A1 COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS NOVARTIS AG (CH) 2016-03-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180170917-A1 COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS BRAF, RAF1, ARAF ALDH1A1 2115/4885CSNK2A1 253/4885HTT 4024/4885
US-10167279-B2 Compounds and compositions as RAF kinase inhibitors BRAF, RAF1, ARAF ALDH1A1 2115/4885CSNK2A1 253/4885HTT 4024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.